Montrealer Michael Santillo was 29 when he was diagnosed with ankylosing spondylitis, a type of inflammatory arthritis. It affected his life, and he struggled with daily tasks like driving or putting ...

The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...

Back in ancient times, the world of medicine was filled with odd remedies and strange cures that claimed to tackle […] ...

The emotional and physical toll doctors battle when they fall sick and become patients, facing the same fears and ...

Even without a lot of social media use, disinformation finds older Americans. It’s on their phones, in their texts, in their ...

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

As millions of Americans experience the benefits of weight loss through the use of GLP-1 medications, some orthopedic experts are still torn on the potential effects the medications will have for ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...

The FDA approved Avtozma, a tocilizumab biosimilar developed by Celltrion, for the treatment of several rheumatic conditions.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.